Daily almond consumption in cardiovascular disease prevention via LDL-C change in the U.S. population: a cost-effectiveness analysis.

Jifan Wang, Michelle A Lee Bravatti, Elizabeth J Johnson, Gowri Raman

Journal: BMC public health 2020;20(1):558

PMID: 32334551

Abstract

BACKGROUND

Heart disease is the leading cause of death in the United States. The U.S. Food and Drug Administration approved the health claim that 1.5 oz (42.5 g) of nut intake may reduce the risk of cardiovascular disease. Previous studies have focused on the cost-effectiveness of other foods or dietary factors on primary cardiovascular disease prevention, yet not in almond consumption. This study aimed to examine the cost-effectiveness of almond consumption in cardiovascular disease primary prevention.

PERSPECTIVE & SETTING

This study assessed the cost-effectiveness of consuming 42.5 g of almond from the U.S. healthcare sector perspective.

METHODS

A decision model was developed for 42.5 g of almond per day versus no almond consumption and cardiovascular disease in the U.S.

POPULATION

Parameters in the model were derived from the literature, which included the probabilities of increasing low-density lipoprotein cholesterol, developing acute myocardial infarction and stroke, treating acute myocardial infarction, dying from the disease and surgery, as well as the costs of the disease and procedures in the U.S. population, and the quality-adjusted life years. The cost of almonds was based on the current price in the U.S. market. Sensitivity analyses were conducted for different levels of willingness-to-pay, the probabilistic sensitivity analysis, ten-year risk prevention, different costs of procedures and almond prices, and patients with or without cardiovascular disease.

RESULTS

The almond strategy had $363 lower cost and 0.02 higher quality-adjusted life years gain compared to the non-almond strategy in the base-case model. The annual net monetary benefit of almond consumption was $1421 higher per person than no almond consumption, when the willingness to pay threshold was set at $50,000 for annual health care expenditure. Almond was more cost-effective than non-almond in cardiovascular disease prevention in all the sensitivity analyses.

CONCLUSION

Consuming 42.5 g of almonds per day is a cost-effective approach to prevent cardiovascular disease in the short term and potentially in the long term.

Address: Tufts University Friedman School of Nutrition and Policy, 150 Harrison Ave, Boston, MA, 02111, USA. [email protected].; Tufts University Friedman School of Nutrition and Policy, 150 Harrison Ave, Boston, MA, 02111, USA.; Tufts Clinical Evidence Synthesis Center, Tufts Medical Center, 800 Washington Street, box 63, Boston, MA, 02111, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.